These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35596633)

  • 1. [Efficacy of newly developed food for special dietary use in the diet of patients with non-alcoholic steatohepatitis].
    Sasunova AN; Morozov SV; Sobolev RV; Isakov VA; Kochetkova AA; Vorobyeva IS
    Vopr Pitan; 2022; 91(2):31-42. PubMed ID: 35596633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modification of dietary patterns in patients with non-alcoholic steatohepatitis].
    Sasunova AN; Goncharov AA; Morozov SV; Isakov VA
    Ter Arkh; 2022 Oct; 94(8):973-978. PubMed ID: 36286977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specialized products for dietary correction of the diet of patients with non-alcoholic steatohepatitis].
    Vorobyeva VM; Vorobyeva IS; Morozov SV; Sasunova AN; Kochetkova AA; Isakov VA
    Vopr Pitan; 2021; 90(2):100-109. PubMed ID: 34019353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An analysis of the efficacy of low-calorie and isocaloric diets in obese patients with nonalcoholic steatohepatitis].
    Selezneva KS; Isakov VA; Sentsova TB; Kirillova OO
    Vopr Pitan; 2014; 83(5):72-8. PubMed ID: 25816629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
    Abd El-Kader SM; Al-Shreef FM; Al-Jiffri OH
    Afr Health Sci; 2016 Mar; 16(1):242-9. PubMed ID: 27358638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dietary correction of metabolic disorders in patients with diabetic nephropathy].
    Sharafetdinov KK; Plotnikova OA; Alekseeva RI; Pilipenko VV; Vorobyeva VM
    Vopr Pitan; 2022; 91(5):87-94. PubMed ID: 36394932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
    Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
    Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isomeric specific analysis of hydroxyeicosatetraenoic acid in blood samples from obese patients with non-alcoholic and alcoholic steatohepatitis].
    Selezneva KS; Isakov VA; Éller KI; Goriainov SV; Kirillova OO; Sentsova TB
    Vopr Pitan; 2014; 83(5):12-9. PubMed ID: 25816621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenetic mechanisms for the development of hematological disorders in induced fatty liver disease in Wistar rats and assessment of the regulatory effects of carnosine and α-lipoic acid].
    Riger NA; Trushina EN; Mustafina OK; Timonin AN; Aksenov IV; Guseva GV; Tutelyan VA
    Vopr Pitan; 2021; 90(3):6-19. PubMed ID: 34264552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
    Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH).
    Capristo E; Miele L; Forgione A; Vero V; Farnetti S; Mingrone G; Greco AV; Gasbarrini G; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):265-8. PubMed ID: 16231587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bioelectrical impedance analysis, mass index, and waist circumference in assessing risk for non-alcoholic steatohepatitis.
    Schwenger KJP; Kiu A; AlAli M; Alhanaee A; Fischer SE; Allard JP
    Nutrition; 2022 Jan; 93():111491. PubMed ID: 34739937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive lifestyle intervention
    Deibert P; Lazaro A; Schaffner D; Berg A; Koenig D; Kreisel W; Baumstark MW; Steinmann D; Buechert M; Lange T
    World J Gastroenterol; 2019 Mar; 25(9):1116-1131. PubMed ID: 30862999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
    Linden MA; Sheldon RD; Meers GM; Ortinau LC; Morris EM; Booth FW; Kanaley JA; Vieira-Potter VJ; Sowers JR; Ibdah JA; Thyfault JP; Laughlin MH; Rector RS
    J Physiol; 2016 Sep; 594(18):5271-84. PubMed ID: 27104887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.
    Shidfar F; Bahrololumi SS; Doaei S; Mohammadzadeh A; Gholamalizadeh M; Mohammadimanesh A
    Can J Gastroenterol Hepatol; 2018; 2018():1053710. PubMed ID: 29850450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls.
    Da Silva HE; Arendt BM; Noureldin SA; Therapondos G; Guindi M; Allard JP
    J Acad Nutr Diet; 2014 Aug; 114(8):1181-94. PubMed ID: 24631112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial.
    Rusu E; Jinga M; Enache G; Rusu F; Dragomir AD; Ancuta I; Draguţ R; Parpala C; Nan R; Sima I; Ateia S; Stoica V; Cheţa DM; Radulian G
    Nutr J; 2013 Aug; 12():119. PubMed ID: 23941362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis.
    Matsumoto M; Hada N; Sakamaki Y; Uno A; Shiga T; Tanaka C; Ito T; Katsume A; Sudoh M
    Int J Exp Pathol; 2013 Apr; 94(2):93-103. PubMed ID: 23305254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low-calorie diet on psoriasis severity index, triglycerides, liver enzymes, and quality of life in psoriatic patients with non-alcoholic fatty liver disease.
    Ismail AMA; Saad AE; Draz RS
    Reumatologia; 2023; 61(2):116-122. PubMed ID: 37223373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.